Page last updated: 2024-08-23

pirazolac and Arthritis, Rheumatoid

pirazolac has been researched along with Arthritis, Rheumatoid in 5 studies

*Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. [MeSH]

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, JA; Kashanian, F; McGee, M; Turner, RA; Turner, SR1
Numo, R1
Dunky, A; Geddawi, M; Kurowski, M2
Clark, B; Geddawi, M; Panayi, G; Symmons, D1

Trials

2 trial(s) available for pirazolac and Arthritis, Rheumatoid

ArticleYear
Multicentre double-blind study of the efficacy, safety and tolerance of pirazolac compared with sulindac in patients with rheumatoid arthritis.
    Drugs under experimental and clinical research, 1990, Volume: 16, Issue:1

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pyrazoles; Randomized Controlled Trials as Topic; Sulindac

1990
Differential dosing study of pirazolac, a new non-steroidal anti-inflammatory agent, in patients with rheumatoid arthritis.
    Current medical research and opinion, 1985, Volume: 9, Issue:8

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Pyrazoles; Random Allocation; Time Factors

1985

Other Studies

3 other study(ies) available for pirazolac and Arthritis, Rheumatoid

ArticleYear
Neutrophil functional and arachidonic acid metabolic correlates and clinical disease activity in pirazolac-treated rheumatoid arthritis patients.
    Drugs under experimental and clinical research, 1990, Volume: 16, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Arthritis, Rheumatoid; Chemotaxis, Leukocyte; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pyrazoles

1990
Effects of pirazolac on arachidonic acid metabolism in the human synovial system.
    Current medical research and opinion, 1987, Volume: 10, Issue:7

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dinoprostone; Fatty Acids, Unsaturated; Female; Humans; Leukotriene B4; Male; Middle Aged; Prostaglandins E; Pyrazoles; Synovial Fluid

1987
Transsynovial distribution and protein binding of pirazolac in patients with rheumatoid arthritis.
    European journal of clinical pharmacology, 1986, Volume: 31, Issue:3

    Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Proteins; Female; Half-Life; Humans; Kinetics; Male; Middle Aged; Osteoarthritis; Protein Binding; Proteins; Pyrazoles; Regression Analysis; Synovial Fluid; Tissue Distribution

1986